Santen Pharmaceutical Correlations
SNPHF Stock | USD 9.73 0.47 5.08% |
The correlation of Santen Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Santen Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Santen Pharmaceutical Co moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Santen Pharmaceutical Co and NYA is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and NYA in the same portfolio, assuming nothing else is changed.
Santen |
The ability to find closely correlated positions to Santen Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Santen Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Santen Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Santen Pharmaceutical Co to buy it.
Moving together with Santen Pink Sheet
Moving against Santen Pink Sheet
0.63 | GOOG | Alphabet Class C | PairCorr |
0.58 | AZNCF | AstraZeneca PLC | PairCorr |
0.56 | AZN | AstraZeneca PLC ADR | PairCorr |
0.44 | NTNX | Nutanix Report 22nd of May 2024 | PairCorr |
0.68 | BAC | Bank of America Financial Report 16th of July 2024 | PairCorr |
0.68 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
0.65 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
0.61 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
Related Correlations Analysis
-0.02 | 0.49 | 0.04 | 0.41 | SNY | ||
-0.02 | -0.52 | 0.58 | 0.04 | BMY | ||
0.49 | -0.52 | -0.73 | -0.15 | AZN | ||
0.04 | 0.58 | -0.73 | 0.56 | GILD | ||
0.41 | 0.04 | -0.15 | 0.56 | NVS | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Santen Pink Sheet performing well and Santen Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Santen Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SNY | 0.98 | (0.04) | 0.00 | (0.17) | 0.00 | 2.03 | 7.04 | |||
BMY | 1.06 | (0.20) | 0.00 | (0.16) | 0.00 | 2.09 | 11.54 | |||
AZN | 0.96 | 0.19 | 0.12 | 0.47 | 1.03 | 2.65 | 7.48 | |||
GILD | 0.82 | (0.32) | 0.00 | (0.47) | 0.00 | 1.32 | 5.55 | |||
NVS | 0.83 | (0.09) | 0.00 | 1.06 | 0.00 | 1.93 | 4.31 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Santen Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Santen Pharmaceutical Corporate Directors
Santen Pharmaceutical corporate directors refer to members of a Santen Pharmaceutical board of directors. The board of directors generally takes responsibility for the Santen Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Santen Pharmaceutical's board members must vote for the resolution. The Santen Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Satoshi Suzuki | Executive Officer, Chief Director of Planning | Profile | |
Kanoko Ohishi | Independent Director | Profile | |
Kenji Morishima | Executive Officer, Chief Director of Human Resources & Organization Development and CSR | Profile | |
Sadatoshi Furukado | Senior Managing Executive Officer, Director of Medical Business, Director | Profile |
Already Invested in Santen Pharmaceutical Co?
The danger of trading Santen Pharmaceutical Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Santen Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Santen Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Santen Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Santen Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |